Nuvation Bio Inc. (NUVB) FY2026 Q2 P&L / Income Statement
2026-04-01 to 2026-06-30
Revenue by Product and Service (2)
2026-04-01 to 2026-06-30
Swipe to see the full flow
Chart details
Nuvation Bio Inc. (NUVB) FY2026 Q2 P&L / Income Statement
Income statement for 2026-04-01 through 2026-06-30. View: Product and service. Revenue uses this breakdown; costs and expenses retain the consolidated categories.
- Total revenue
- 31,687,000 US dollars
- Total costs and expenses
- 82,723,000 US dollars
- Loss from operations
- negative 51,036,000 US dollars
- Total other (expense) income, net
- negative 11,804,000 US dollars
- Income (loss) before income taxes
- negative 62,840,000 US dollars
- Provision for income taxes
- 0 US dollars
- Net loss
- negative 62,840,000 US dollars
- Product
- 23,192,000 US dollars
- License
- 8,495,000 US dollars
- Total costs and expenses
- 82,723,000 US dollars
Chart connections
- Revenue minus operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.
Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG
Operating margin
−161.1%
Operating profit / revenue
Product waitlist
Health Check and Teardown for your own company
A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!